Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
04/2002
04/25/2002US20020048571 Chimeric polypeptides of serum albumin and uses related thereto
04/25/2002US20020048565 Mammalian tolloid-like gene and protein
04/25/2002US20020048562 Tolerogenic fusion proteins of immunoglobulins and methods for inducing and maintaining tolerance
04/25/2002US20020048271 Methods and composition for restoring conformational stability of a protein of the p53 family
04/25/2002DE10149740A1 Method for producing ultraviolet resistant trees and forming woods and forests comprises planting seedlings whose chromosomes ploid is multiploid such as triploid or tetraploid obtained by breeding mutation or artificial crossing
04/25/2002DE10052492A1 Genetically modified monocotyledon plant cell useful for synthesis of modified starch, comprises an extraneous polynucleotide that codes for a protein with the biological activity of an R1 protein from Solanum tuberosum
04/25/2002DE10051542A1 Fluid for transporting or rinsing organs, e.g. kidneys, for transplantation, containing antisense oligonucleotide to reduce expression of transplant damaging materials
04/25/2002DE10050123A1 Verfahren zur Herstellung von Aminosäuren A process for the production of amino acids
04/25/2002DE10050091A1 New casein-derived peptide with growth promoting activity, useful as additive for eukaryotic cell cultures and for recombinant protein production
04/25/2002DE10049673A1 Enzymatic synthesis of peptide, its mimic or protein, useful e.g. in drug development, using a modified ligase adapted to a particular ester leaving group
04/25/2002DE10048091A1 Anwendung chemisch modifizierter Oligodesoxyribonukleotide zur Unterdrückung der Proliferation von humanem Pankreastumor Use of chemically modified oligodeoxyribonucleotides of suppressing the proliferation of human pancreatic tumor
04/25/2002DE10047951A1 Verfahren zur Stimulation der Paarung von Mikroorganismen in Flüssigmedium Method for stimulating the mating of microorganisms in liquid medium
04/25/2002DE10045123A1 New transcription factor gene from Candida albicans, and its related polypeptide and antibody, useful for diagnosis and treatment of candida infection and for drug screening
04/25/2002CA2818654A1 Pregnancy-associated plasma protein-a2 (papp-a2)
04/25/2002CA2464121A1 Pregnancy-associated plasma protein-a2 (papp-a2)
04/25/2002CA2426594A1 Production of .alpha.-hydroxy-carboxylic acids using a coupled enzyme system
04/25/2002CA2426424A1 Haemophilus influenzae basb206 gene and protein
04/25/2002CA2426403A1 Isocitrate dehydrogenase, gene thereof, and use of the same in the treatment of obesity, hyperlipidemia, and fatty liver in lipid biosynthesis
04/25/2002CA2426371A1 Human tuberoinfundibular peptide of 39 residues
04/25/2002CA2426366A1 Fusion cells and cytokine compositions for treatment of disease
04/25/2002CA2426196A1 Simultaneous quantification of nucleic acids in diseased cells
04/25/2002CA2426142A1 A combined electroporation and microinjection method for the penetration of lipid bilayer membranes
04/25/2002CA2426086A1 Regulation of promoter activity using a polypeptide isolated from lactococcus lactis
04/25/2002CA2426084A1 Improved fermentation method for production of heterologous gene products in lactic acid bacteria
04/25/2002CA2425963A1 Human kinases
04/25/2002CA2425927A1 Cytochrome p450 monooxygenases consisting of thermophilic bacteria
04/25/2002CA2425873A1 Imaging of enzymatic activity
04/25/2002CA2425763A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
04/25/2002CA2425742A1 Methods of selecting compounds for modulation of bladder function
04/25/2002CA2425723A1 Neuromedin u delta
04/25/2002CA2425669A1 Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis
04/25/2002CA2425614A1 Plant cell death system
04/25/2002CA2425605A1 Nucleic acid ligands to the prostate specific membrane antigen
04/25/2002CA2425392A1 Reducing oxidative stress of plants by increasing glutathione content
04/25/2002CA2425380A1 Transgenic plants
04/25/2002CA2425362A1 Basb208 nucleotide and amino acid sequences from haemophilus influenzae
04/25/2002CA2425221A1 Protein c or activated protein c-like molecules
04/25/2002CA2425174A1 Human gene critical to fertility
04/25/2002CA2424643A1 Cd38 modulated chemotaxis
04/25/2002CA2422867A1 Improved formulations using heat shock/stress protein-peptide complexes
04/25/2002CA2418835A1 Protein scaffolds for antibody mimics and other binding proteins
04/25/2002CA2359992A1 Rapid extraction of hair root dna
04/24/2002EP1199372A2 Polymorphisms in the human P2X7 gene
04/24/2002EP1199371A2 Methods for identifying products employing reporter gene expression
04/24/2002EP1199368A2 Use of adenoviral e4 reading frames to improve expression of a gene of interest
04/24/2002EP1199367A1 Polypeptides
04/24/2002EP1199366A1 Method for cloning and expression of BSMI Restriction-Modification system in E.coli
04/24/2002EP1199365A2 Method for cloning and expression of BpmI restiction endonuclease in E. coli
04/24/2002EP1199364A2 Use of recombinant enzymes for preparing GDP-L-fucose and fucosylated glycans
04/24/2002EP1199363A1 Phosphorylation modifications of apoptin
04/24/2002EP1199362A2 Immunoregulator from the family designated 'leukocyte immunoglobulin-like receptors' (LIR)
04/24/2002EP1199361A2 Glycoprotein hormone receptor molecules. Their uses
04/24/2002EP1199360A2 Active and inactive CC-chemokine receptors and nucleic acid molecules encoding said receptor
04/24/2002EP1199359A1 Human metabotropic glutamate receptor subtypes (HMR4, HMR6, HMR7) and related DNA compounds
04/24/2002EP1199356A2 Highly productive alpha-amylases
04/24/2002EP1199355A1 Sulfur atom-free enzyme proteins
04/24/2002EP1199080A2 Co-administration of interleukin-3 mutants with colony stimulating factors
04/24/2002EP1198985A1 Method for superrapid transformation of monocotyledon
04/24/2002EP1198598A1 Prophage dna sequences and their use in determining instability in lactobacilli cultures
04/24/2002EP1198595A1 Methods and compositions for detecting pathological events
04/24/2002EP1198594A2 Polymerase extension at 3' terminus of pna-dna chimera
04/24/2002EP1198593A1 Amplification method for detection of target nucleic acids involving fluorescence energy transfer
04/24/2002EP1198592A1 Oligonucleotides incorporating both 2-aminoadenine and 5-substituted pyrimidines
04/24/2002EP1198591A1 Nanoparticles having oligonucleotides attached thereto and uses therefor
04/24/2002EP1198590A2 Polynucleotide sequencing using a helicase
04/24/2002EP1198589A1 Tenascin-c nucleic acid ligands
04/24/2002EP1198586A1 An in vivo library-versus-library selection of optimized protein-protein interactions
04/24/2002EP1198584A1 Transcription-based gene mapping
04/24/2002EP1198583A1 Mutant tn5 transposase enzymes and method for their use
04/24/2002EP1198582A1 Freeze/thawed lipid complexes and their preparation
04/24/2002EP1198581A1 Structural protein of adeno-associated virus with modified antigenicity, its production and its use
04/24/2002EP1198580A1 Scleroprotein of an adeno-associated virus with modified chromatographic properties, the production thereof and use of the same
04/24/2002EP1198579A1 Non-human adenoviral vector for gene transfer, its use and the production thereof
04/24/2002EP1198578A2 PLANT S-ADENOSYLMETHIONIN:Mg-PROTOPORPHYRIN-IX-O-METHYLTRANSFERASE, PLANTS WITH VARIABLE CHLOROPHYLL CONTENTS AND/OR HERBICIDE TOLERANCE, AND METHOD FOR THE PRODUCTION THEREOF
04/24/2002EP1198577A1 Mutant gene of the gras family and plants with reduced development containing said mutant gene
04/24/2002EP1198576A1 Sink protein
04/24/2002EP1198575A1 Isoprenoid biosynthesis
04/24/2002EP1198574A2 Soluble, active recombinant human mao-b
04/24/2002EP1198573A2 Polynucleotides encoding aminolevulinic acid biosynthetic enzymes
04/24/2002EP1198572A2 Method for generating cgmmv resistant plants, genetic constructs, and obtained cgmmv-resistant plants
04/24/2002EP1198571A2 Chimeric proteins
04/24/2002EP1198570A1 Monomeric protein of the tgf-beta family
04/24/2002EP1198569A1 G-protein coupled receptor and dna sequences thereof
04/24/2002EP1198568A1 Compositions and methods for the treatment of immune related diseases
04/24/2002EP1198567A1 Novel uses of abca-type transporters
04/24/2002EP1198566A2 Method for high-throughput selection of interacting molecules
04/24/2002EP1198565A1 A method for preparing modified polypeptides
04/24/2002EP1198564A2 Mutant bacterial strains l-lysine production
04/24/2002EP1198563A2 Novel fibroblast growth factor and nucleic acids encoding same
04/24/2002EP1198561A1 Thermostable nucleoside diphosphate kinase for nucleic acid detection
04/24/2002EP1198560A2 Mammalian adhesion protease peptides
04/24/2002EP1198559A1 Means and methods for nucleic acid transfer
04/24/2002EP1198556A2 Methods for producing and preparing cells for cell therapy
04/24/2002EP1198489A1 Combinations for introducing nucleic acids into cells
04/24/2002EP1198480A2 Hybridomas for lung cancer marker and monoclonal antibodies thereof
04/24/2002EP1198479A1 Neovascular-targeted immunoconjugates
04/24/2002EP1198477A1 Prolactin-releasing peptide and method for regulating autonomic functions and treating pain
04/24/2002EP1198475A1 Highly purified cytokine activating factor and methods of use
04/24/2002EP1198468A1 Stabilized viral envelope proteins and uses thereof
04/24/2002EP1198255A1 Identification of compounds that modify transcriptional responses to hypoxia